Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Kyowa Hakko prepares new, water-soluble indole for osteoporosis

Dec. 12, 1997

Tokyo Tanabe moves new oxytocin antagonist to clinic

Dec. 12, 1997

FDA approves SERM for preventing postmenopausal osteoporosis

Dec. 11, 1997

Potential new male contraceptive under development in China

Dec. 11, 1997

Sparta acquires rights to PZG

Dec. 10, 1997

TH-9507 proceeds to toxicological studies

Dec. 10, 1997

BioTime reports preliminary phase III data from Hextend trial

Dec. 9, 1997

Lilly discovers highly potent and selective NPY Y1 receptor antagonists

Dec. 9, 1997

NPS and SmithKline Beecham sign additional extension of osteoporosis agreement

Dec. 9, 1997

HMR begins phase II trial with GA-EPO

Dec. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...